Historical record - last NADAC effective date: 12/18/2019
Product Information
THERAFLU EXPRESSMAX COLD NT LQ is a brand product labeled by Haleon US Holdings LLC, priced at $0.0221 per ML under NDC 00067812908. Its NADAC has been published 220 times since Apr 20, 2016.
Strength
650; 25; 10 mg/30mL; mg/30mL; mg/30mL
Manufacturer
Haleon US Holdings LLCNDC
00067812908
Classification
Brand
Dosage Form
SYRUP
Route
ORAL
Effective Date
12/18/2019
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/15/2015
Pharmacological Classes
Price Statistics
The NADAC for THERAFLU EXPRESSMAX COLD NT LQ has been published 220 times since Apr 20, 2016, and over the history we have for it it has risen 8.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0221 per ML |
|---|---|
| All-time high | $0.0238 (Nov 13, 2019) |
| All-time low | $0.0200 (May 18, 2016) |
| Median price | $0.0213 |
| Average price | $0.0215 |
| Largest weekly change | +12.1% (Mar 22, 2017) |
| Weeks tracked | 220 |
| Tracking since | Apr 20, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+8.5%
Last surveyed Jul 1, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of THERAFLU EXPRESSMAX COLD NT LQ?
The current National Average Drug Acquisition Cost (NADAC) for THERAFLU EXPRESSMAX COLD NT LQ, manufactured by Haleon US Holdings LLC, is $0.0221 per ML (NDC 00067812908), effective Jul 1, 2020.
How has the price of THERAFLU EXPRESSMAX COLD NT LQ changed over time?
Over the history we have for it, the NADAC for THERAFLU EXPRESSMAX COLD NT LQ has risen 8.5%. It has been tracked across 220 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for THERAFLU EXPRESSMAX COLD NT LQ?
Since Apr 20, 2016, the NADAC for THERAFLU EXPRESSMAX COLD NT LQ has ranged from a low of $0.0200 (May 18, 2016) to a high of $0.0238 (Nov 13, 2019), with a median of $0.0213 per ML.
Are there cheaper alternatives to THERAFLU EXPRESSMAX COLD NT LQ?
No other NADAC-published product currently shares the active ingredient and strength of THERAFLU EXPRESSMAX COLD NT LQ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures THERAFLU EXPRESSMAX COLD NT LQ?
THERAFLU EXPRESSMAX COLD NT LQ (NDC 00067812908) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.